These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Tipoe GL, Ho CT, Liong EC, Leung TM, Lau TY, Fung ML, Nanji AA. Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863 [Abstract] [Full Text] [Related]
28. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway. Zhang W, Wu R, Zhang F, Xu Y, Liu B, Yang Y, Zhou H, Wang L, Wan K, Xiao X, Zhang X. Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227 [Abstract] [Full Text] [Related]
29. JIP3 knockout protects mice against high fat diet-induced liver injury. Ma XJ, Xing HZ, Ren GF, Rao XJ, Li ZZ. Biochem Biophys Res Commun; 2018 Mar 11; 497(3):819-826. PubMed ID: 29454969 [Abstract] [Full Text] [Related]
33. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. He Q, Xia X, Yao K, Zeng J, Wang W, Wu Q, Tang R, Zou X. Life Sci; 2019 Dec 15; 239():117010. PubMed ID: 31672578 [Abstract] [Full Text] [Related]